D

Dragonfly Research, LLC | Wellesley, MA

Research site

(Unclaimed)

Location

110 Cedar Street, Suite 110, Wellesley, Massachusetts, United States of America

Site insights

Top conditions

Top treatments

Ocrelizumab

Ofatumumab

Interferon

ATA188

Natalizumab

Fenebrutinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 11 total trials

A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis (FENtrepid)

A study to evaluate the efficacy and safety of fenebrutinib on disability progression in adult participants with Primary Progressive Multiple Scleros...

Active, not recruiting

Multiple Sclerosis, Primary Progressive

Drug: Placebo matched to ocrelizumab

Drug: Placebo matched to fenebrutinib

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)

This is a randomized, double blind, controlled, parallel group, multicenter study to evaluate efficacy, safety and pharmacokinetics of a higher dose...

Active, not recruiting

Multiple Sclerosis

Drug: Antihistamine

Drug: Ocrelizumab

Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS (ALITHIOS)

The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have particip...

Active, not recruiting

Relapsing Multiple Sclerosis

Biological: 23-valent pneumococcal polysaccharide vaccine (23-PPV)

Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)